13.10.2012 • News

Applikon Biotechnology Starts Construction of New Facility in Delft

Applikon Biotechnology, a private Dutch company specialized in the development, manufacture and supply of bioreactor systems for both research and production use, has started the construction of a new facility on the high-tech science park Technolopis in Delft. The building with offices, laboratories, a workshop and warehouse will accommodate approximately 100 people.

 

 

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.